Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04017130
Title A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Efficacy of TAK-169 in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Millennium Pharmaceuticals, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Southern California Los Angeles California 90033 United States Details
Mayo Clinic - Jacksonville Jacksonville Florida 32224 United States Details
Miami University Miami Florida 33136 United States Details
Northside Hospital Atlanta Georgia 30342 United States Details
Mayo Clinic - Rochester Rochester Minnesota 55905 United States Details
The Ohio State University Columbus Ohio 43201 United States Details
Vanderbilt University Medical Center- Ingram Cancer Center Nashville Tennessee 37203 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field